Currently Viewing
Ovarian Cancer: Enrolling in Clinical Trials
January 23, 2017
The Role of BRCA Testing in Ovarian Cancer
January 23, 2017

Ovarian Cancer: Enrolling in Clinical Trials

Kathleen Moore, MD, emphasizes the importance of enrolling patients with ovarian cancer onto clinical trials. In this segment, Dr. Moore describes which patients are the best candidates for PARP inhibitor therapy and why these and other patients will benefit from clinical trial participation.
PUBLISHED January 23, 2017

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In